Corvus Pharmaceuticals Inc
NASDAQ:CRVS

Watchlist Manager
Corvus Pharmaceuticals Inc Logo
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Watchlist
Price: 7.8 USD 4.14% Market Closed
Market Cap: 582.5m USD

Wall Street
Price Targets

CRVS Price Targets Summary
Corvus Pharmaceuticals Inc

Wall Street analysts forecast CRVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRVS is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 25.2 USD.

Lowest
Price Target
11.11 USD
42% Upside
Average
Price Target
15.64 USD
101% Upside
Highest
Price Target
25.2 USD
223% Upside
Corvus Pharmaceuticals Inc Competitors:
Price Targets
ASND
Ascendis Pharma A/S
30% Upside
MNKD
MannKind Corp
54% Upside
6855
Ascentage Pharma Group International
86% Upside
6160
Beigene Ltd
34% Upside
UTHR
United Therapeutics Corp
1% Upside
VNDA
Vanda Pharmaceuticals Inc
70% Upside
688105
Nanjing Vazyme Biotech Co Ltd
45% Upside
ADAG
Adagene Inc
400% Upside

Revenue
Forecast

Revenue Estimate
Corvus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Corvus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Corvus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRVS's stock price target?
Price Target
15.64 USD

According to Wall Street analysts, the average 1-year price target for CRVS is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 25.2 USD.

Back to Top